We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
GeneThera Inc (CE) | USOTC:GTHR | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
(
Check
One
):
|
☒
Form 10-K
|
☐
Form 20-F
|
☐
Form 11-K
|
☐
Form 10-Q
|
☐
Form 10-D
|
☐
Form N-SAR
|
☐
Form N-CSR
|
|
☐
Transition Report on Form 10-K
|
|
☐
Transition Report on Form 20-F
|
|
☐
Transition Report on Form 11-K
|
|
☐
Transition Report on Form 10-Q
|
|
☐
Transition Report on Form N-SAR
|
☐
|
(a)
|
The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
☒
|
(b)
|
The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K, 10-Q, Form N-SAR, or portion thereof,
will be filed on or before the nineteenth calendar day following
the prescribed due date; or the subject quarterly of transition
report on Form 10-K, or portion thereof be filed on or before the
fifth calendar day following prescribed due date; and
|
|
|
|
☐
|
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification.
|
|
Tannya L. Irizarry
|
(303)
|
506-9367
|
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify report(s). ☒
Yes ☐ No
|
(3)
|
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
☐
Yes ☒ No
|
|
|
Date:
March 28, 2019
|
By: /s/
TANNYA L. IRIZARRY
|
|
Tannya
L. Irizarry
|
|
CFO
(Interim)
|
1 Year GeneThera (CE) Chart |
1 Month GeneThera (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions